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Editor, 
We report on a 22 year-old non-smoking nulligravida who presented with her husband for in 
vitro fertilisation (IVF). She was in good general health and had five prior unsuccessful IVF 
treatments, all with implantation failure. While her TSH and T4 were normal, a strongly positive 
(1:25,600) thyroid peroxidase antibody (ATA) titre was noted. Their sixth IVF cycle included 
IVIG infusion x3 as had been used in the immediately preceding cycle. However, etanercept 
(Enbrel®; Immunex Corp., Thousand Oaks, California USA) was added for the first time as a 
series of 25mg subcutaneous injections commencing four weeks before ovulation induction and 
continued on four-day intervals thereafter. Eight etanercept injections were given until 
commencement of gonadotropins, and then discontinued. Two blastocysts were transferred 
fresh and two were frozen at day five. Following an unremarkable obstetrical course, the patient 
delivered male/male twins by Caesarean at 34½ weeks' gestation. While the strongly positive 
ATA titre finding in our patient was concerning, we admitted that the mechanism of how ATA 
impacts reproductive outcome is presently unknown. ATA have been documented more often in 
women with recurrent pregnancy failure than controls, and a prospective clinical trial of women 
with “immunologic abortion” evaluating multiple autoimmune variables found ATA to be the 
most frequently encountered immunopathology—present in 53% of patients1.Our case, believed 
to be the first published report of its kind in Ireland, is parallel with those who have described a 
highly-circumscribed use of immunomodulators for refractory cases where an immune diathesis 
exists2,3 and given only under closely monitored conditions. While immunomodulators are 
inappropriate in IVF for unselected populations and should not be regarded as first-line therapy, 
dampening of immune responses antagonistic to implantation and embryo development may be 
a derivative of IVIG + etanercept therapy. Should our patient decide to enlarge her family and 
return for transfer of cryopreserved embryos in future, the role of further immunomodulator 
treatment will require consideration. 
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